Private Equity
The Federal Economic Development Agency for Southern Ontario (FedDev Ontario) has provided $600,000 in funding to GreenMantra Technologies, a Canadian maker of specialty chemicals, such as waxes, greases and lubricants, from recycled plastics. FedDev said the Brantford, Ontario-based company raised an additional $1.2 million from angel investors led by Arctern Ventures and Cycle Capital. The investment follows GreenMantra's raise of $5.5 million earlier this month. FedDev Ontario said its repayable contribution will primarily support market development for the company's Ceranovus A-Series waxes.
3 min read · 21 June 2016
GreenMantra Technologies, a producer of specialty chemicals from recycled plastic feedstocks, recently raised $5.5 million in follow-on financing. The investment, the first tranche of a larger round of funding, was backed by the company's existing investors: Canadian venture capital firms ArcTern Ventures and Cycle Capital. Kousay Said, GreenMantra's president and CEO, said the proceeds of the round will fund a next stage of growth for the company, primarily to bring several new products to market and provide working capital. The Brantford, Ontario-based company raised $17 million in a series of financings in 2014.
3 min read · 21 June 2016
GreenMantra Technologies, a producer of specialty chemicals from recycled plastic feedstocks, recently raised $5.5 million in follow-on financing. The investment, the first tranche of a larger round of funding, was backed by the company's existing investors: Canadian venture capital firms ArcTern Ventures and Cycle Capital. Kousay Said, GreenMantra's president and CEO, said the proceeds of the round will fund a next stage of growth for the company, primarily to bring several new products to market and provide working capital. The Brantford, Ontario-based company raised $17 million in a series of financings in 2014.
3 min read · 21 June 2016
TVM Capital Life Science has made an undisclosed investment in Mediti Pharma Inc, a Montréal-based developer of a treatment for Alzheimer’s disease psychosis. The company, which is led by CEO Dr. Ivan Shaw and CFO Mark Cipriano, plans to use the proceeds of the financing to develop MP-101, a Phase 2-ready clinical compound originally discovered by Eli Lilly and Co. TVM Capital Life Science, which has offices in Munich, Germany and Montréal, made the investment via TVM Life Science Ventures VII, which raised US$201.6 million in October 2014.
4 min read · 21 June 2016
TVM Capital Life Science has made an undisclosed investment in Mediti Pharma Inc, a Montréal-based developer of a treatment for Alzheimer’s disease psychosis. The company, which is led by CEO Dr. Ivan Shaw and CFO Mark Cipriano, plans to use the proceeds of the financing to develop MP-101, a Phase 2-ready clinical compound originally discovered by Eli Lilly and Co. TVM Capital Life Science, which has offices in Munich, Germany and Montréal, made the investment via TVM Life Science Ventures VII, which raised US$201.6 million in October 2014.
4 min read · 21 June 2016
The Canadian affiliate of U.K. insurance firm Aviva plc plans to host a first-ever Pitch Day event in Toronto on October 11, 2016. Through a selection process, the top 10 Canadian digital startup submissions will pitch to a panel of Aviva advisors to be considered for an investment of up to $10 million. The potential investment will be made by Aviva Ventures, Aviva's corporate venture capital fund. The fund is currently investing $180 million over the next five years in digital companies located around the globe.
3 min read · 20 June 2016
The Canadian affiliate of U.K. insurance firm Aviva plc plans to host a first-ever Pitch Day event in Toronto on October 11, 2016. Through a selection process, the top 10 Canadian digital startup submissions will pitch to a panel of Aviva advisors to be considered for an investment of up to $10 million. The potential investment will be made by Aviva Ventures, Aviva's corporate venture capital fund. The fund is currently investing $180 million over the next five years in digital companies located around the globe.
3 min read · 20 June 2016
New York-based advertising technology company Collective has raised US$34 million in follow-on funding. The round was led by Columbia Partners and was joined by Accel Partners, Greycroft and Canadian venture capital firm iNovia Capital. Founded in 2005, Collective offers enterprises data-driven and programmatic solutions to unify digital advertising across platforms, screens and formats. Joe Apprendi, the company's founder and CEO, said the latest investment will allow Collective to accelerate the roll-out of new product features and functionality later this year and in 2017.
3 min read · 17 June 2016
Canadian real estate technology platform Real Matters Inc has appointed Blaine Hobson its new chairman. Hobson, a partner at Canadian venture capital firm Whitecap Venture Partners, has been a long-standing director of the company. Whitecap led Real Matter's seed funding in 2007 and has participated in most of the company's investments since then, including the $100 million round announced in April. Hobson also represents Whitecap on the board of directors of portfolio company Qvella, a molecular diagnostics company.
4 min read · 16 June 2016
Canadian real estate technology platform Real Matters Inc has appointed Blaine Hobson its new chairman. Hobson, a partner at Canadian venture capital firm Whitecap Venture Partners, has been a long-standing director of the company. Whitecap led Real Matter's seed funding in 2007 and has participated in most of the company's investments since then, including the $100 million round announced in April. Hobson also represents Whitecap on the board of directors of portfolio company Qvella, a molecular diagnostics company.
4 min read · 16 June 2016
